Latest Immunosuppressive drug Stories
One human antibody known as BI 655066 is a promising candidate to be used to target the inflammation-causing protein, interleukin-23.
HILDEN, Germany, and GERMANTOWN, Maryland, January 27, 2015 /PRNewswire/ -- - QuantiFERON Monitor (QFM(R)) launches in Europe for monitoring immune
A newly discovered tick-borne bacterium known as “Candidatus Neoehrlichia mikurensis” has been implicated in six cases of disease in Sweden.
WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill.
New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV.
Decision Alleviates Concerns Over Potential for Organ Rejections, Preserves Physician Discretion Over Patient Care WASHINGTON, March 13, 2014 /PRNewswire-USNewswire/ -- Kidney Care
AUSTIN, Texas, Jan. 16, 2014 /PRNewswire/ -- XBiotech announced today that it has launched a Phase II study to treat a rare but debilitating disorder, Pyoderma Gangrenosum (PG).
- Large; stout; burly.